AR087582A1 - COMPOSITION FOR INHALATION OF DRY POWDER, PROCESS, METHOD - Google Patents
COMPOSITION FOR INHALATION OF DRY POWDER, PROCESS, METHODInfo
- Publication number
- AR087582A1 AR087582A1 ARP120103027A AR087582A1 AR 087582 A1 AR087582 A1 AR 087582A1 AR P120103027 A ARP120103027 A AR P120103027A AR 087582 A1 AR087582 A1 AR 087582A1
- Authority
- AR
- Argentina
- Prior art keywords
- dry powder
- composition
- inhalation
- range
- capped
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 229960005018 salmeterol xinafoate Drugs 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La composición para inhalación de polvo seco que comprende: (1) xinafoato de salmeterol con un tamaño de partícula promedio en la escala de 2.0 - 6 mm y una densidad taponada en la escala de 0.20 g.cm⁻³ a 0.45 g.cm⁻³; y (2) opcionalmente, uno o más ingredientes activos. Y un conductor farmacéuticamente aceptable.The dry powder inhalation composition comprising: (1) salmeterol xinafoate with an average particle size in the range of 2.0 - 6 mm and a density capped in the range of 0.20 g.cm⁻³ to 0.45 g.cm⁻ ³; and (2) optionally, one or more active ingredients. And a pharmaceutically acceptable driver.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP120103027 AR087582A1 (en) | 2012-08-16 | 2012-08-16 | COMPOSITION FOR INHALATION OF DRY POWDER, PROCESS, METHOD |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP120103027 AR087582A1 (en) | 2012-08-16 | 2012-08-16 | COMPOSITION FOR INHALATION OF DRY POWDER, PROCESS, METHOD |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR087582A1 true AR087582A1 (en) | 2014-04-03 |
Family
ID=50686543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120103027 AR087582A1 (en) | 2012-08-16 | 2012-08-16 | COMPOSITION FOR INHALATION OF DRY POWDER, PROCESS, METHOD |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR087582A1 (en) |
-
2012
- 2012-08-16 AR ARP120103027 patent/AR087582A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014002087A (en) | Pyrethroid formulations. | |
| PE20140255A1 (en) | DISPERSIBLE TABLET IN ORAL FORM | |
| EP2571486A4 (en) | Dry powder inhalation composition | |
| IN2013MU03583A (en) | ||
| WO2015044782A3 (en) | Intranasal dhe for the treatment of headache | |
| WO2015056094A3 (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent | |
| PH12015502542B1 (en) | Stabilized pemetrexed formulation | |
| CR20150455A (en) | IMIDAZOPIRIDAZINAS REPLACED | |
| MX2014008033A (en) | Method and device for fast dissolution of solid protein composition. | |
| EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| NZ710602A (en) | Methods for reducing pyrogenicity in a seaweed extract | |
| NZ702930A (en) | Racecadotril liquid compositions | |
| TN2015000413A1 (en) | Child-resistant zipper assemblies and packages utilizing the same | |
| NZ702415A (en) | Methods for treating neutropenia using retinoid agonists | |
| DOP2014000269A (en) | NEW DOSAGE AND FORMULATION | |
| MY163476A (en) | Oral care compositions | |
| MX357704B (en) | O/w-emulsion-type topical pharmaceutical compositions containing a retinoid. | |
| MX375187B (en) | DRY PHARMACEUTICAL COMPOSITIONS COMPRISING NANOPARTICLES OF ACTIVE AGENT LINKED TO CARRIER PARTICLES. | |
| CL2012003250A1 (en) | Use of a galactolipid in combination with ascorbic acid and / or a derivative thereof that serves to protect a composition against oxidation; method for the preparation of the composition, composition; and product. | |
| PH12016501045B1 (en) | Method for preparing dry powder inhalation compositions | |
| AR087582A1 (en) | COMPOSITION FOR INHALATION OF DRY POWDER, PROCESS, METHOD | |
| IN2013MU03428A (en) | ||
| PL2629765T3 (en) | Methods and compositions for treating pox virus infections with an 1,4-naphthoquinone as active agent | |
| IN2015DN03920A (en) | ||
| PH12015502029A1 (en) | Phenylephrine resinate particles and use thereof in pharmaceutical formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |